Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$207,319,240
-$41,904,378 QoQ
Shares Held
8,609,603
-3.0% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#63
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. PFE ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,333,307 | $1,599,208,548 | |
| 2 | JNJ |
Johnson & Johnson
|
3,780,752 | $960,197,585 | |
| 3 | ABBV |
AbbVie Inc.
|
2,733,648 | $687,895,182 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,809,518 | $489,523,063 | |
| 5 | AMGN |
Amgen Inc
|
904,954 | $327,701,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,051,819 | $259,226,812 | |
| 7 | PFE |
Pfizer Inc
This page
|
8,609,603 | $207,319,240 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,347,347 | $192,874,134 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $207,319,240 | 8,609,603 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $249,223,618 | 8,875,485 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $219,365,339 | 8,809,853 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $230,012,673 | 9,027,185 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $218,659,344 | 9,020,600 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $239,707,176 | 9,459,636 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $256,628,589 | 9,673,147 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $281,545,828 | 9,728,605 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $278,628,393 | 9,958,127 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $277,321,040 | 9,993,551 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $296,417,147 | 10,295,837 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $345,747,295 | 10,423,494 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $378,063,180 | 10,307,066 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $414,258,801 | 10,153,402 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $500,250,073 | 9,762,882 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $410,711,099 | 9,385,537 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $485,769,979 | 9,265,115 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $453,283,417 | 8,755,716 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $508,274,587 | 8,607,529 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $368,717,461 | 8,572,831 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $328,311,996 | 8,383,861 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $325,776,210 | 8,991,891 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $347,152,680 | 9,430,934 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $344,296,379 | 9,381,382 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $303,796,949 | 9,290,417 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $288,266,428 | 8,831,704 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||